Macuject

AI assisting doctors treating macular degeneration

Problem

Age-related macular degeneration is the leading cause of blindness in Australia.
Lifelong eye injections can prevent or reverse blindness in 95% of cases.
The effectiveness of treatment is limited by a shortage of retinal specialists.

Solution

Macuject tackles the issue of macular degeneration with AI-driven software.
The software aids in identifying macular degeneration and offers decision support for clinicians.
It enhances the delivery of optimal care by improving diagnostic accuracy and treatment planning.

Outcome

Macuject was founded by Dr. Devinder Chauhan, a leading ophthalmologist.
Curve served as the technical lead, supporting Dr. Chauhan’s mission to enhance patient care.
The collaboration aims to improve lives through advanced diagnostic and treatment solutions for macular degeneration.